PEPTIDE VACCINE FOR CANCER THERAPY

摘要

A method for treating a cancer patient involving the administration of a therapeutically effective amount of cancer antigens to a patient requiring the same, characterized by comprising: 1) providing a set of cancer antigen peptides consisting of two or more cancer antigen peptides; 2) evaluating the presence or absence of specific cytotoxic T lymphocyte precursors for individual peptides contained in the cancer antigen peptide set in the patient; 3) removing a cancer antigen peptide, concerning which the patient is evaluated as having no cytotoxic T lymphocyte precursor specific thereto, from the cancer antigen peptide set to thereby prepare a cancer antigen peptide set for administration; and 4) administering the cancer antigen peptide set to the patient.